
that further expand the scope of
outpatient services. But the cur-
rent debate on national health
care also raises a red flag, Aster
admits, especially since more
than two-thirds of Vivra's dia-
lysis revenues are paid by Medi-
care -~ and Medicare's reim-
bursements already are lower
than they were 10 years ago.
There's talk in Washington of
increasing dialysis payments by
2.5% a year, he adds, but
whether the increase will actu-
ally go through remains any-
one's guess.
  On the other hand, Aster
avers, reduced payments would
drive out more marginal opera-
tors, giving Vivra even more

